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Craniofacial bones derive from cephalic neural crest, by endochondral or intramembranous ossification. Here, we address the role of the
homeobox transcription factor Dlx5 during the initial steps of calvaria membranous differentiation and we show that Dlx5 elicits Runx2 induction
and full osteoblast differentiation in embryonic suture mesenchyme grown “in vitro”. First, we compare Dlx5 expression to bone-related gene
expression in the developing skull and mandibular bones. We classify genes into three groups related to consecutive steps of ossification.
Secondly, we study Dlx5 activity in osteoblast precursors, by transfecting Dlx5 into skull mesenchyme dissected prior to the onset of either Dlx5
and Runx2 expression or osteogenesis. We find that Dlx5 does not modify the proliferation rate or the expression of suture markers in the
immature calvaria cells. Rather, Dlx5 initiates a complete osteogenic differentiation in these early primary cells, by triggering Runx2, osteopontin,
alkaline phosphatase, and other gene expression according to the sequential temporal sequence observed during skull osteogenesis “in vivo”.
Thirdly, we show that BMP signaling activates Dlx5, Runx2, and alkaline phosphatase in those primary cultures and that a dominant-negative Dlx
factor interferes with the ability of the BMP pathway to activate Runx2 expression. Together, these data suggest a pivotal role of Dlx5 and related
Dlx factors in the onset of differentiation of chick calvaria osteoblasts.
© 2007 Elsevier Inc. All rights reserved.Keywords: Dlx5; Runx2; Chick embryo; Bone differentiation; Primary calvaria cells; Transfection; FGF receptor; BMP; alkaline phosphataseIntroduction
During embryogenesis and early post-natal life, brain and
skull growth are coordinated by the maintenance of the cranial
sutures, e.g. undifferentiated areas located between the ossified
skull plates. At the edge of the developing bones, the osteogenic
fronts (OFs), the osteoblast precursors proliferate actively then
differentiate (Holleville et al., 2003; Iseki et al., 1997, 1999;⁎ Corresponding author. Institut Curie, Centre de Recherche, Orsay F-91405,
France. Fax: +331 69 86 3017.
E-mail address: anne-helene.monsoro-burq@curie.u-psud.fr
(A.–H. Monsoro-Burq).
1 Both authors have contributed equally to this work.
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.01.003Opperman, 2000; Rice et al., 2003). Mutations in FGF and
BMP pathways or transcription factors such as Twist and Msx
genes result in skull malformations, due to either delayed or
premature ossification of the suture mesenchyme (Lenton et al.,
2005). These signals pattern the localized activation of essential
regulators of osteogenesis such as Dlx5, Runx2, and Osterix
(Osx) (Ryoo et al., 2006). Dlx5 mutant mice present delayed
skull ossification as well as severe craniofacial defects
(Acampora et al., 1999). Skull ossification does not occur in
Dlx5/Dlx6 double mutant mice, reflecting redundant activities
of Dlx5 and Dlx6 in this process (Beverdam et al., 2002; Depew
et al., 2002; Merlo et al., 2002; Robledo et al., 2002). Runx2
controls osteoblast maturation in all skeletal elements, both in
chondroblasts and osteoblasts, whereas Osx controls terminal
osteoblast differentiation (Nakashima et al., 2002).
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and the role of Dlx5 and Runx2 genes during bone development.
In the skull, Dlx5 is expressed in neural crest-derived osteoblasts
progenitors, before the onset of skull osteogenesis (Holleville et
al., 2003). Dlx5 expression is regulated by BMP2 both in vivo
(Holleville et al., 2003) and in cell lines (Lee et al., 2003). In the
C2C12 myoblast cell line, which undergoes transdifferentiation
towards osteoblasts when triggered by BMP2, Dlx5 is an
immediate early target of BMP2 signaling, thus appearing before
osteogenic differentiation (Lee et al., 2003). Furthermore, Dlx5
activity is required for BMP2-mediated C2C12 cells transdiffer-
entiation and Runx2 expression (Ryoo et al., 2006). In addition
to this early role, e.g. before the initiation of differentiation, the
basal levels of Dlx5 expression observed in fetal osteoblast cell
lines are further upregulated during the late mineralization stage
(Ryoo et al., 1997). Runx2 is regulated negatively by Msx and
Twist, and positively by TGFβ1, BMP2, and Dlx5 (Ryoo et
al., 2006; Blin-Wakkach et al., 2001; Dodig et al., 1999; Liu et
al., 1999; Bialek et al., 2004).
Osteogenic mesenchyme development is controlled by sur-
rounding structures such as the ectoderm or the dura mater
(Francis-West et al., 1998;Kim et al., 1998;Takahashi et al., 1991).
In this study, we first describe similar and unique gene expression
inmembranous bones located at two distinct craniofacial locations:
(i) in the calvaria, where bones form between dura mater and
dermis/ectoderm, and (ii) in the mandibula, where membranous
bones differentiate in the vicinity of Meckel’s cartilage, under the
control of ectoderm and mesenchymal signals. We analyze the
patterns of pre-osteoblast and early osteoblast markers (Dlx5,
FGFRs, BMPs,Msx1/2, Goosecoid, Twist, that we had previously
described in the chick frontal OFs) as well as other genes involved
in mandibula patterning and bone formation (Runx2, Prx1, Pitx1,
Dlx2) (Ducy et al., 1999; Komori et al., 1997; Lanctot et al., 1999;
Martin et al., 1995). Prx1 is a homeobox-containing gene,
expressed in the mesenchyme of facial skeletal precursors,
involved in the early epithelial–mesenchymal interactions
controlling skeletogenesis (Kuratani et al., 1994; Martin et al.,
1995).Dlx2 and Pitx1 are involved in early mandibula patterning
(Lanctot et al., 1999; Qiu et al., 1995, 1997).
Secondly, we address the role of Dlx5 in the initiation of the
osteogenic program in primary cells derived from immature
suture mesenchyme. It is clear from numerous studies that
overexpression of Dlx5 in fetal osteoblasts, or osteoblast cell
lines, stimulates bone differentiation (Miyama et al., 1999;
Newberry et al., 1998; Tadic et al., 2002). However, these cells
are already engaged in osteogenic differentiation and express
basal levels of Dlx5 and Runx2 (Miyama et al., 1999). In the
C2C12 transdifferentiation assay, forced expression of Dlx5
without additional BMP signals, stimulates Runx2 expression
but is not sufficient for Osx or osteocalcin induction (Ryoo
et al., 2006). Moreover, in another study carried out using
older fetal (E21) rat calvaria and osteosarcoma cells ROS 17/2.8,
Dlx5 repressed osteocalcin promoter but did not modify osteo-
pontin and alkaline phosphatase expression (Ryoo et al., 1997).
This shows that Dlx5 may display different roles according to
the differentiation status of the cell. Altogether, these studies
show a role for Dlx5 in the progression of the osteogenicprogram, but do not address the role of Dlx5 on immature
progenitors, and whether Dlx5 can drive a complete osteogenic
program from such progenitor cells. Using uncommitted calvaria
precursors, we show here that (i) Dlx5 switches on a sequential
series of gene expressions, similar to the ones described in vivo,
(ii) Dlx5 activates a complete osteogenic program, including
Runx2, osteopontin, and alkaline phosphatase expression, and
(iii) a dominant-negative Dlx homeodomain construct interferes
with BMP-induced Runx2 activation in these primary cells.
Material and methods
In situ hybridization (ISH) on paraffin sections
Fertile Gallus gallus eggs, JA 57 or Haas strains, were incubated for 7 to
12 days (E7 to E12) at 38 °C. Heads were dissected in ice-cold PBS, fixed,
embedded in wax, and sectioned (7 mm thick sections, Leica RM2145
microtome). Alternate serial sections were probed with different genes and are
presented in Supplemental Fig. 1 for close details of the suture. Antisense RNA
probes were synthesized using Riboprobe Combination System SP6/T7 kit
(Promega) as described previously for Msx1 and Msx2 (Monsoro-Burq et al.,
1995); Bmp2 and Bmp4 (Francis-West et al., 1994); FGF-R1, -R2 (Wilke et al.,
1997); Dlx5 (Pera et al., 1999); Bmp7 (Wang et al., 1999); Goosecoid (Goos;
Izpisua-Belmonte et al., 1993); Prx1 (Kuratani et al., 1994); Pitx1 (Logan and
Tabin, 1999); and Dlx2 (Puelles et al., 1999). The osteopontin, tissue non-
specific alkaline phosphatase (Alk. Phos.) and Twist probes were kind gifts of
Drs. P. Castagnola, J-L Millán, and M-C. Delfini. Chick Runx2 gene was cloned
from E2–2.5 chick embryo RNA (RNAble kit, Eurobio) by RT-PCR
amplification using specific primers: 5′-ATG CGT. ATC CCC GTA GAT RCC
AGC-3′ and 5′-TCAGTAKGGCCKCCANACVGC-3′ (Enhanced Avian RT-
PCRKit, Sigma). Sectionswere stained either with NBT-BCIP (Roche) or Vector
Red (Vector), after ISH procedure according to Etchevers et al. (2001).
Cell culture and transfection
E6/6.5 head ectoderm and mesenchyme from the frontal area, or mandibular
mesenchyme were dissected out in PBS. The ectoderm and meningis were
removed by a mild pancreatin treatment (Gibco BRL). All visible Meckel’s
cartilage rudiments were carefully dissected out. The mesenchyme was further
dissociated by a mild trypsin digestion, or dissociated through a syringe needle,
centrifuged, and collected in a complete culture medium (DMEM supplemented
with 10% fetal calf serum, 1% penicillin–streptomycin and 1% glutamine
(Gibco BRL)). For low density short-term culture (Fig. 5), the cells were plated
in 96-well plates at a density of 1000 cells per square-cm. To improve survival of
the cells, other cultures were seeded at a density of 42,000 cells per square-cm
(Figs. 6–8). The culture would not survive in the absence of serum, which
prevented us from addressing the role of Dlx5 in serum-free medium. After 7–
9 days of culture in DMEM, 10% fetal calf serum, 1% penicillin–streptomycin
and 1% glutamine, the medium was supplemented with 50 μg/ml of acid
ascorbic and 10 mM of β-GPO4, in order to allow bone differentiation (thus
named “differentiation medium”). This technique was modified from previous
protocols developed for older primary chick calvaria cells or transdifferentiation
assays (Gerstenfeld et al., 1987; Poliard et al., 1995).
We have constructed an expression vector encoding the complete ORF of
chick Dlx5 (chDlx5, a generous gift of Dr. M. Kessel, GenBank™ accession
number U25274). ChDlx5 was subcloned into BamH1/Xho1 of the pCDNA3
vector (Invitrogen). The activation of BMP signaling was achieved using a
constitutively activated BMP Type I receptor (AcBMPR, Q233D) cloned in
pCS107, a kind gift of Dr. R. Harland. The dominant-negative Dlx construct
(DlxHD-EnR) consists of the fusion of zebrafish Dlx3 (homologous to Xenopus
and chick Dlx5) homeodomain to the strong Engrailed Repressor domain (EnR).
This construct was a generous gift of Dr. K. Artinger (Woda et al., 2003).
The cells were transfected 18–24 h after plating, at about 50–60%
confluence, either with control pCDNA3, control pCS107, pCS2-GFP,
pCDNA3-Dlx5, pCS107-AcBMPR, pCS2-DlxHD-EnR, or a combination of
these. We have used Transfectam® (Transfectam® Reagent, Promega) or
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6 h of incubation, fresh medium containing 10% serum was added. Medium was
changed every 2 days. The short-term cultures were analyzed at 24, 48, or 92 h
post-transfection (equivalent to E8, E9, and E12, assuming that the timing of
development in vivo and in vitro can be compared). The transfection efficiency by
Dlx5was determined by staining forDlx5mRNA (ISH) or protein immunostaining
(see below). In most low density experiments, more than 90% of the cells were
positive. The higher density cultures were analyzed at day 3 to 17.
We have also tried to cultivate early mandibula mesenchyme, dissected out
at E4. These cells grow well in vitro when not transfected. Unfortunately, using
four alternative transfection methods (Transfectam, Lipofectamin Plus,
Effectene (Qiagen), and Exgene (Euromedex)), we did not get a good survival
of the transfected cells and could not use this type of cultures for further analysis
(not shown).
In situ hybridization and immunocytochemistry on primary chick
calvaria cells
The cultures were rinsed in PBS, fixed in 4% formaldehyde/PBS, directly
prehybridized, and stained according to standard procedures. Some cultures
were stained with a polyclonal pan-Dlx antibody, a kind gift of Dr. J. Kohtz,
raised as described in (Kohtz et al., 2001; Panganiban et al., 1995). To monitor
cell proliferation, BrdU incorporation was performed during 4 h before fixation
and analyzed using the Cell proliferation kit (Amersham Pharmacia Biotech).
Following short-term culture, about a hundred cells were counted in the center of
each well. Within each series of experiments, three replicates were done for each
assay (in situ hybridization for each gene or BrdU analysis). A total of five
independent series of experiments were done. The percent of positive cells in
about 1500 cells is reported in Figs. 5M, N.
Bone sialoprotein promotor reporter assay
The transactivating or repressor potential of chDlx5 and DlxHD-EnR
constructs were tested using the trimerized Dlx5-binding C-element of the bone
sialoprotein promotor, a gift of Dr. Franceschi (Benson et al., 2000). BHK21
cells were transfected using Exgen (Euromedex). Luciferase assays were
performed 36–48 h after transfection using Promega Dual Luciferase Reporter
Assay System.Results
Nested patterns of Dlx5, Runx2, and Prx1 during chick frontal
bone ossification
We have previously described the coordinate expression of
BMP2/4/7, Msx1/2, Dlx5, FGFR1/2/4, and Twist genes in the
frontal suture and bones of chick embryo calvaria. We have
also shown that Dlx5 is activated in proliferating osteoblast
precursors at 7/8 days of development (E7–8), i.e. before any
osteoblast differentiate in this area, and is maintained during
the early stages of differentiation (Holleville et al., 2003). At
E12, the frontal bones are still separated by an open suture.
Thus, on the same transverse section, both undifferentiated
mesenchyme and differentiated osteoblasts can be observed
(Figs. 1A–B). The suture's mesenchyme and the outer part of
the OFs comprise immature progenitors, whereas the inner part
of the OFs and the bone are formed by more mature and
differentiated osteoblasts respectively. Here, we compare
the E12 expression patterns of Dlx5 (Figs. 1C, C′), Runx2
(Figs. 1D, D′), Prx1 (Figs. 1E, E′), alkaline phosphatase
(Figs. 1F, F′), Pitx1, and Dlx2 (not shown) on adjacent
sections. Dlx5 is expressed in the mesenchyme located aroundthe bone, in a domain where osteoprogenitors have not yet
differentiated (Fig. 1C). Dlx5 is excluded from the differ-
entiated bone (expressing osteopontin (not shown) and alka-
line phosphatase (Fig. 1F)), and from the sutural mesenchyme
in the midline (Fig. 1C′). The highest level of expression is
found at the OFs (Fig. 1C′). In addition, some Dlx5-
expressing cells are found located farther from the OFs
towards the midline (see Supplemental Fig. 1 for high
magnification pictures). Similarly, Runx2 delineates the outer
limit of the differentiated bone, the highest levels of
expression being found at the OFs (Figs. 1D–D′). Runx2
expression corresponds to the area that expresses the highest
levels of Dlx5. Neither the undifferentiated sutural mesenchyme
at the midline nor the mineralized structures express Runx2
(Fig. 1D′). We detect Prx1 transcripts in the undifferentiated
sutural mesenchyme (Fig. 1E′). Prx1 is thus expressed outside of
the Dlx5- and Runx2-positive domains (Fig 1E). These observa-
tions suggest that Prx1 labels immature osteoblasts precursors at
an earlier stage of their development than Dlx5 and Runx2.
Expression of the definitive bone marker alkaline phosphatase is
found in cells lining the mineralized bone and within the bone
plate (Figs. 1F, F′). We did not detect Pitx1 orDlx2 expression in
the chick frontal area from E9 to E16 (not shown).
Comparative gene expression during calvaria and mandibula
membranous ossification
We then examined several gene expression patterns during
membranous bone formation, in E7–E12 chick mandibula.
The neural crest-derived mandibular mesenchyme differenti-
ates into Meckel’s cartilage and several membranous bones
around it: the articular, angular, supra-angular, dentary
splenial, and mentomandibula bones (Couly et al., 1993; Le
Lievre, 1978) (Fig. 3B).
Dlx5, Bmp7, and Bmp4 expression partially overlap in E7
mandibular arch
In early skull mesenchymal condensations, Dlx5 activation
is correlated with areas of Bmp4 and Bmp7 coexpression
(Holleville et al., 2003). In the mandibula at E7, Meckel’s
cartilage is surrounded by undifferentiated mesenchymal
condensations. Membranous bone elements start to differentiate
around E8, as detected by alizarin red staining (not shown). The
undifferentiated mesenchyme located aroundMeckel’s cartilage
strongly expresses Dlx5: at E7, there is an enhanced Dlx5
expression ventral to Meckel’s cartilage (Fig. 2A, bracket 1) and
at the junction between the maxillary process and mandibular
arch (Fig. 2A, bracket 2) (Fig. 2D, pink shade). Bmp7 is
expressed in the mandibular mesenchyme on both sides of
Meckel’s cartilage, coincindent with the strongest levels of
Dlx5 (Fig. 2B, brackets 1 and 2). Bmp7 expression is also
observed in Dlx5-negative domains, such as the mesenchyme
and epithelium of the tongue primordium and the maxillary
mesenchyme (Figs. 2B, D, blue dots). A gradient of Bmp4
expression from mandibular epithelium to the underlying
mesenchyme has been reported between stages 24 and 28
(E6) (Barlow and Francis-West, 1997; Francis-West et al.,
Fig. 1. Expression of Dlx5, Runx2, Prx1, and alkaline phosphatase in frontal bone osteogenic fronts at E12. (A) A cleared skeletal preparation of an E12 chick embryo
head is shown in dorsal view, anterior to the left. The white bar indicates the level of the transverse sections shown in panels B–F. The cartilage is stained with alcian
blue, and the bone with alizarin red. (B) Schematic representation of the sections shown in panels C–F, with dorsal to the top. The nasal septum cartilage (ns) is shown
in blue, bilateral frontal bone elements are in red. The red square indicates the frames of panels C–F sections. (C, C′) In situ hybridization (ISH) for Dlx5 shows a
strong staining around the ossified element, enlarged area in panel C′ is indicated by the box in panel C. (D, D′) ISH for Runx2 on an adjacent section shows that
Runx2 domain overlaps with Dlx5 domain. (E, E′) Prx1 is expressed in the suture mesenchyme, outside Dlx5 domain. (F, F′) Alkaline phosphatase is expressed
in the cells lining the ossified element, inside Dlx5 domain. The black arrows in panels C′, D′, E′, and F′ indicate the most medial extent of the mineralized bone.
Additional adjacent sections shown at high magnification are shown in Supplemental Fig. 1.
863N. Holleville et al. / Developmental Biology 304 (2007) 860–8741994). At E7, Bmp4 is expressed in the mesenchyme underlying
the oral epithelium in the mandibula, the tongue and the
maxillary process (Figs. 2C, D, green). Thus, Dlx5 activation
around Meckel’s cartilage surrounds the areas of high Bmp7
expression but Dlx5 expression is not as closely correlated to
Bmp4 expression as observed in frontal bone progenitors.
Nested gene expression patterns in E12 mandibula
We analyzed markers for mesenchyme, pre-osteoblasts, and
osteoblasts, as well as members of BMP and FGF signalingpathways (a total of 15 genes) on alternate sections at E12 (Figs.
3 and 4). In each panel, the lateral part of mandibula is oriented
towards the left and the medial part is on the right. The genes are
grouped according to their expression in the immature me-
senchyme (Fig. 3, group 1) and in progressively more mature
cells, closer to the differentiated bone: pre-osteoblasts, early
osteoblasts, and embedded osteoblasts (Fig. 4, groups 2 and 3).
At E12, Dlx5 expression outlines each membranous bone
(Figs. 3A and B) and is not expressed in Meckel’s cartilage.
Dlx5 is excluded from the differentiated osteoblasts but is
Fig. 2. Expression of Bmp2, Bmp4, and Bmp7 compared to Dlx5 in the mandibula of E7 chick embryos. (A) In transverse sections through the head of E7 embryos,
Dlx5 is expressed in the mesenchyme of the mandibular arch (bracket 1) and at the junction between the mandibula and the maxillary processes (bracket 2). Meckel's
cartilage (Mc) does not express Dlx5. (B) Bmp7 is expressed within Dlx5 domain (brackets 1 and 2), in the tongue and maxillary processes and in the facial ectoderm.
(C) Bmp4 is found farther from the Dlx5-positive areas, under the oral and tongue ectoderm and in the maxillary process. (D) schematic illustrates the overlap of the
expression of Dlx5 (pink), Bmp7 (blue), and Bmp4 (green) in the mandibula of E7 chick embryos.
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osteoblasts (Fig. 3C). The expression patterns of the other
genes are compared to the Dlx5-positive area, and described
either as located “farther” or “closer” to the differentiated cells
(the bone is delimited by a dotted line). None of these genes is
detected in Meckel’s hypertrophic cartilage (Figs. 3 and 4).
Prx1 andPitx1 expression is observed the farthest from the bone
(Figs. 3D, E). Prx1 is strongly expressed in undifferentiated
mesenchyme (Fig. 3D′). As observed around the frontal bones, a
Prx1-negative area surrounds the bones (Fig. 3D′, compare to
Dlx5 in Fig. 3C).Pitx1 is weakly expressed as a fine line around the
pre-osteoblast area except at the tip of the bone element (Figs. 3E
and E′). Twist, Msx1, and FgfR2 label both the immature mesen-
chyme located distal to the bone elements and the cells within the
Dlx5-positive area (Figs. 3F–H′). In contrast, Msx2 appears as a
weak and scattered pattern around the OFs of the membranous
bones, hardly above background levels (Figs. 3I and I′).
Goosecoid, Dlx2, and Runx2 are detected in a similar pattern
to that of Dlx5, although Dlx2 is weakly expressed at this stage(Figs. 4A–C′). As noted earlier in the skull, Runx2 and Dlx5
domains again overlap (compare Fig. 3C and Fig. 4C′). Bmp2
and Bmp4 are expressed in the pre-osteoblasts lining bones
(Figs. 4D–E). Moreover, Bmp2 is found in some early
osteoblasts not yet embedded in the bone matrix (Fig. 4D′). In
contrast, Bmp7 is located mainly around the tips of the bones
(Figs. 4F and F′). As in the calvaria, FgfR1 and osteopontin
(osp) genes are expressed in early and differentiated osteoblasts,
surrounded by bone matrix (Figs. 4G–G′, H–H′).
From this comparative analysis, we conclude that the general
gene expression pattern during mandibula membranous ossifi-
cation is similar to what is reported in the calvaria. Prx1 labels
the immature mesenchyme. Runx2 and Dlx5 domains mainly
overlap. However, a few differences between the two locations
are observed. At E12, Twist and Goosecoid are hardly detected
in the mandibula whereas their expression is prominent in the
frontal area. Secondly, Pitx1 and Dlx2 are found around
mandibula bone primordia but not in the frontal area at any of
the stages analyzed.
Fig. 3. Expression of immature osteoblast progenitor markers in E12 chick mandibula. The expression of a series of genes present around the developing bones was
compared to expression of Dlx5, in the mandibular membrane bones that form around Meckel's cartilage. (A) Dlx5 is expressed in the immature osteoblasts lining the
membrane bones (schematized in red in panel B). (C) Enlargement at the position indicated by the star in panel A shows the respective position of Dlx5-positive cells
and mineralized structure (dotted line). Adjacent sections show expression of Prx1 (D, D′), Pitx1 (E, E′), FgfR2 (F, F′), Twist (G, G′), Msx1 (H, H′), and Msx2 (I, I′)
in general view (D-I) and enlargements at the level indicated by the star (D′-I′). See text for the comparative analysis of these expression patterns. All these markers are
expressed outside Dlx5-positive domain compared to the mineralized bone (indicated by the dotted line).
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Fig. 4. Expression of committed and mature osteoblast markers in E12 chick embryo mandibula. The expression of Dlx5 was further compared to that of its putative
target Goosecoid (A, A′), Dlx2 (B, B′), the committed osteoblast marker Runx2 (C, C′), Bmp2 (D, D′), Bmp4 (E, E′), and Bmp7 (F, F′). These genes have overlapping
expression domains. In contrast FgfR1 (G, G′) and osteopontin (H, H′) are expressed by the embedded osteoblasts. See text for details.
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osteogenic program
In order to address the role of Dlx5 during the onset of
osteogenesis in the calvarial progenitors, we have over-
expressed Dlx5 in suture mesenchyme. Due to the low
proliferation rate in the immature suture areas, RCAS retro-
virus-mediated infection “in vivo” and in explants failed.
Therefore, we have transfected Dlx5 expression plasmid into
primary cultures of calvaria mesenchyme. Previous studies have
used differentiated Dlx5-positive fetal osteoblasts. Here we
have dissected E6–6.5 immature mesenchyme located in thefrontal area and prospective coronal suture domain (Fig. 5A), in
order to collect calvaria progenitors before they activate
endogenous Dlx5 gene expression (Holleville et al., 2003).
We address three questions: (1) does Dlx5 act on cell
proliferation, (2) does Dlx5 overexpression activate a subset or
all of the genes detected during the different steps of early
osteogenesis in Figs. 3 and 4, (3) does Dlx5 trigger terminal
osteogenic differentiation in these cells grown in vitro? Cells
transfected with the control plasmid do not expressDlx5 after 1–
9 days in culture (as detected by ISH (B, B′) or immunostaining
(not shown)), showing that the cells have not received sufficient,
if any, Dlx5-inducing signals before they are isolated, and that
Fig. 5. Dlx5 induces the expression of early osteoblast markers in short-term culture of immature calvaria mesenchyme. Dlx5 was transfected into primary cultures of
immature, non committed calvaria mesenchyme, taken at E6 in the frontal area of chick embryos (A, indicated by red dash). The control cells do not express either
Dlx5 or Runx2 at the time of explantation or later in vitro. B: in situ hybridization for Dlx5, B′: phase contrast of the same culture. The percent of positive cells is
quantified in panels M and N.Dlx5was efficiently transfected into these primary cells (C: in situ hybridization, D, Dll antibody staining, M). Proliferation was analyzed
(E, M). The expression of the immature mesenchyme markers FgfR2 (F), Twist (G, control; G′ transfected by Dlx5), of the committed osteoblasts Runx2 (H),Msx1 (I),
Goosecoid (J) and differentiated osteoblasts FgfR1 (K) and osteopontin (L) were analyzed and quantified (M, N; blue bar indicates percent of positive cells in control
pCDNA-transfected culture, red bar indicate percent of positive cells in Dlx5-transfected culture).
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(Figs. 5B, B′). In the short-term culture condition, an average of
94% of the cells transfected with pCDNA3-Dlx5 express Dlx5
after 48 h in culture (detected by in situ hybridization or
immunocytochemistry using an anti-Dll polyclonal antibody)
(Figs. 5C, D,M).We have detectedDlx5 expression up to 4 days
after transfection.Dlx5 does not alter pre-osteoblast proliferation or
mesenchymal marker expression (Prx1, Twist), but it does
enhance FgfR2 expression
The expression of Dlx5 by proliferating pre-osteoblasts from
E7–8 onwards suggests that Dlx5 could participate in either
control of their proliferation or in the onset of their differentia-
tion program (Holleville et al., 2003). Here, we have analyzed
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observed in vivo, the proliferation rate of these primary cells is
low. After Dlx5 transfection, we do not observe a significant
increase in cell proliferation (Figs. 5E, M). In the frontal area,
the suture mesenchyme expresses both Twist, Prx1, and FgfR2
whereas cells around the OFs express Dlx5, Twist, and FgfR2.
In control cultures, 28% of the cells expressed FgfR2, 41%
Prx1, and 62% Twist. Dlx5 expression results in the significant
upregulation of FgfR2 (88% of positive cells) but not of Twist
(77% of positive cells) or Prx1 (36% of positive cells), at
24–36 h after transfection in the primary calvaria mesench-
yme (Figs. 5F–G). In conclusion, Dlx5 does not significantly
modify suture mesenchyme markers Twist and Prx1 expres-
sion, nor cell proliferation, but is able to markedly increase
FgfR2 expression.
Dlx5 induces committed and mature osteoblast markers
Subsequently, we have analyzed the expression of genes
present in pre-osteoblasts both in skull and mandibula
progenitors (Runx2, Msx1, Goosecoid), and in mandibula only
(Dlx2, Pitx1). Additionally we have examined genes expressed
by the mature osteoblasts in both locations (FgfR1 and osteo-
pontin). We have also looked at Msx2 expression, although it is
present only at background levels in both skull and mandibula at
E12 (Fig. 3). Results are shown in Figs. 5H–N. Runx2, Msx1,
Pitx1, Dlx2, and osteopontin are virtually not expressed in
control calvaria mesenchyme (less than 10% of the cells, Fig.
5N). As observed on sections, Msx2 expression is comparable
to background, no differences are observed between control
cells and Dlx5-transfected cultures (not shown). Goosecoid and
FgfR1 are present at basal level of expression in 25% and 18%
of the cells, respectively. As early as 24 h after Dlx5
transfection, the calvaria precursors exhibit a marked induction
of Runx2 and Msx1 expression (64% and 78% of the cells,
respectively, Figs. 5H–I) as well as a strong increase in Goo-
secoid expression (75%, Fig. 5J). Similarly, Dlx5 induces a
strong expression of Dlx2 and Pitx1 after 24 or 36 h
(respectively 77% and 73% of positive cells, Fig. 5N). FgfR1
expression is upregulated by Dlx5 overexpression 48-h post-
transfection (Figs. 5K, N). A few Osteopontin-expressing cells
are observed 92 h after transfection of pCDNA3-Dlx5 (Figs. 5L,
N). This experiment shows that transfection of Dlx5 in the
progenitors of skull bones elicits induction/overexpression of
the genes described in vivo, in a temporal manner reflecting
the maturation steps of the osteoblasts. Surprisingly, Dlx2
and Pitx2 are also activated in skull progenitors in vitro,
although their in vivo expression is restricted to the mandi-
bula. This suggests that local regulation, potentially pro-
vided by surrounding tissue, may be missing in our culture
conditions.
Long-term cultures reveal that Dlx5 drives terminal bone
differentiation from immature mesenchyme
To fully assay bone differentiation, we have developed long-
term culture conditions for the immature E6 calvaria progeni-
tors, which are based on established conditions used for in vitro
differentiation of E16 chick calvaria or C1 mesoderm cell line(Gerstenfeld et al., 1987; Poliard et al., 1995). In contrast to late
stage osteoblasts, the E6 immature cells are difficult to grow for
long periods (2–3 weeks). When several culture wells are
inoculated in parallel from the same cell suspension, only a
small subset of the wells grow efficiently as confluent
monolayers, necessitating multiple replicates in each experi-
ment. Higher cell density somewhat improves culture survival.
Using these novel long-term conditions, we have analyzed the
expression of alkaline phosphatase, a widely accepted marker
of definitive bone, in cultured E6 calvaria progenitors. Three
independent experiments have been performed. Cultures are
analyzed at day 3/4 post-transfection for Runx2 and osteo-
pontin expression, and later switched to differentiation medium
on day 9. Alkaline phosphatase expression is analyzed at day 9
and day 16–17 post-transfection. Control cultures do not show
either Dlx5, Runx2, osteopontin, or alkaline phosphatase
expression (in the case of alk. phos., 7/9 control cultures do
not exhibit any positive cells, 2/9 cultures had a few sparse
positive cells, not shown). As in lower density culture, Dlx5 is
efficiently transfected, as detected 3–4 days after transfection
(not shown). Runx2 is detected in most of the cells at D3–4
(Figs. 6A, B) but not at D9–11 and D14–17 (not shown).
Osteopontin is found in a few cells at D3–4 (Figs. 6C, D)
and shows similar weak expression at D9 and D11 (not
shown). Alkaline phosphatase expression is found in sparse
cells at E9 in the absence of differentiation medium (not
shown). In contrast, when cells are grown in differentiation
medium for 3 to 8 days, strong and widespread alkaline
phosphatase staining is observed in the Dlx5-transfected
cultures (10/10 cultures analyzed), most often in dense areas
of the culture (Fig. 6E).
We conclude that when Dlx5 is expressed in E6 calvaria
progenitors grown in vitro for short and long periods, the cells
recapitulate the sequential steps of bone differentiation
observed in vivo. Specifically, we demonstrate that Dlx5
overexpression does not affect cell proliferation but instead
activates or enhances the expression of several genes expressed
at the osteogenic fronts in vivo, including a sustained Runx2
expression during the first days. Subsequently, our analysis of
long-term E6 calvaria cells reveals that Dlx5 can promote full
bone differentiation in culture.
Dlx activity is essential for BMP-mediated Runx2 activation in
primary calvaria cells
Our previous work has shown that Dlx5 is activated by
BMP signals in chick calvaria. Moreover, BMP signals acti-
vate both Dlx5 and Runx2 expression as well as bone dif-
ferentiation in various cell contexts. Here, we have activated
BMP signaling in a cell-autonomous manner, by transfecting
the E6 calvaria cells with a constitutively active type I BMP
receptor (AcBMPR, Fig. 7). Three to four days after trans-
fection, both Dlx5 (Figs. 6A, B) and Runx2 (Figs. 6C, D) are
activated in the AcBMPR-transfected cultures whereas the
control cultures remain negative. Under long-term culture
conditions using differentiation medium, alkaline phospha-
tase-positive cells can differentiate (Figs. 6E, F).
Fig. 6. Dlx5 induces Runx2, osteopontin, and alkaline phosphatase in long-term culture of immature calvaria mesenchyme. High density culture of immature E6 chick
calvaria was assayed for induction of the definitive bone marker alkaline phosphatase. In these condition, Dlx5 induces Runx2 and osteopontin expression at 3–4 days
in culture as observed in low density short-term cultures (A: Runx2 expression at D4 in Dlx5-transfected culture, B: ISH for Runx2 at D4 in control pCDNA3-
transfected culture; C, D: osteopontin expression at D4 in Dlx5 and control cultures). Alkaline phosphatase expression is induced at D16 in Dlx5-transfected but not in
control cultures (E, F).
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critical for the initiation of Runx2 in immature calvaria
mesenchyme triggered by BMP signals, we use here a
dominant-negative construct encoding zebrafish Dlx3 home-
odomain fused to the repressor domain of Engrailed (DlxHD-
EnR, Woda et al., 2003). First, we demonstrate that this
construct interferes with chick Dlx5 transactivating activity. For
this, we used the Dlx5-binding element of the bone sialoprotein
(BSP) promotor driving luciferase as a reporter construct
(Benson et al., 2000) and performed luciferase reporter assays in
BHK21 cells. We observe that the DlxHD-EnR specifically
represses the endogenous activity of the promotor in BHK21
cells (Fig. 8A). Moreover, chick Dlx5 activates the promoter
3–4-fold above endogenous levels (Fig. 8B). Increasing
concentrations of DlxHD-EnR co-transfected with chick Dlx5
decrease this activation (Fig. 8B). Secondly, we tested if
DlxHD-EnR interferes with Runx2 activation by BMP signals.
DlxHD-EnR prevents the induction of Runx2 by AcBMPR in
the E6–6.5 calvaria cells (Fig. 8C). This shows that a Dlx-type
activity is essential for the induction of Runx2 by BMPs in this
system. Finally, in order to see if Dlx-EnR can also interfere
with endogenous Runx2 expression, we transfected E6–6.5mandibular mesenchyme cells, that already express Runx2 in
control transfections. We observe a general decreased (but not
abolition) of Runx2 expression in those cultures (Fig. 8C),
showing that the activity of Dlx factors plays a role in the
maintenance of Runx2 expression.
Discussion
Dlx5 and Runx2 are major regulators of bone differentiation.
However, the precise role of the Dlx5 homeoprotein during the
development of embryonic skull progenitors, specifically at the
osteogenic front, remains to be addressed. Here, we ask three
questions: is Dlx5 activity important for proliferation of
progenitors pools, is Dlx5 activity important for initiating the
osteogenic program (i.e. Runx2 activation), and is Dlx5
sufficient to drive a complete osteogenesis from immature
calvaria progenitors (i.e. promoting Runx2 induction and
definitive bone markers expression)?
The analysis of these questions by a loss of function
approach in mouse embryos is hampered by the redundant
activities of Dlx6 and Dlx5. In the Dlx5 mutant mice, Runx2 is
activated normally in the ribs but expression in the skull
Fig. 7. BMP signals activateDlx5, Runx2, and alkaline phosphatase expression in chick immature calvaria cells. E6–E6.5 calvaria primary cells were transfected with
an activated type I BMPR or a control expression vector. While control transfections remain negative (A, C, E), AcBMPR transfection results in the activation of Dlx5
(B), Runx2 (D) at day 4, and Alkaline Phosphatase (F) at day 17. Scale bar=200 μm.
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Depew et al., 1999). In addition, skull ossification is delayed but
not absent, suggesting that the main bone differentiation signals
are activated to a certain extent in these mutants. In contrast,
Dlx5/Dlx6 double mutants exhibit a complete absence of
calvaria, among other severe skeletal and non-skeletal defects
(Robledo et al., 2002). In long bones of the double mutants,
Runx2 is expressed normally but the analysis of Runx2
activation in early skull progenitors, before exencephaly occurs,
has not been reported. Hence, the dependence upon Dlx5/6
activity for Runx2 initiation in skull progenitors remains to be
analyzed.
Previous reports have analyzed the effects of Dlx5 over-
expression either in established cell lines, or at late osteogenesis
stages, which already display high endogenous Dlx5 and Runx2
expression levels (see for example Ryoo et al., 2006). Here, we
use primary chick calvaria dissected at E6 to analyze Dlx5
activity at the earliest steps of intramembranous bone
differentiation. To do so, we first analyze multiple gene
expression patterns in the skull and in the mandibula of chick
embryos; we describe common and specific characteristics for
different stages of osteoblast development for each of the skullor mandibula primordium. We then cultivate early primary
calvaria cells to identify the genes regulated by Dlx5 activation
and the phenotype of these cells.
By the detailed analysis of an array of fifteen genes on serial
sections, we propose that three main domains can be defined,
which are similar in the developing membrane bones of skull
and mandibula. We further use this classification to define the
state of commitment of the cells in culture. First, the most
immature areas, which are located most distal to bone, express a
combination of Prx1, FgfR2, and Twist genes. This area
corresponds essentially to the sutural mesenchyme in the skull
(Fig. 1 and Holleville et al., 2003) and is located around the
future membranous bones in the mandibula (Fig. 3). This
pattern of gene expression is related to areas where the mesen-
chyme is maintained in an undifferentiated state, to prevent
premature fusion of the bones. It was shown that Prx1 is critical
for the formation of the pre-skeletal mesenchymal condensa-
tions (Martin et al., 1995) and that Prx1 is a negative regulator
of osteoblast differentiation by binding to the collagen I alpha-I
and the Osteocalcin promoters (Hu et al., 1998). Additionally,
Twist and FgfR2 have been implicated in the maintenance of
the proliferative state in mouse calvaria (Anderson et al., 1998;
Fig. 8. A Dlx dominant-negative construct interferes with Dlx5 activity and prevents Runx2 activation by BMP signals. A Dlx homeodomain fused to Engrailed
Repressor domain (DlxHD-EnR) is used to block Dlx-like activity in two systems. First, reporter assays using the Dlx5-binding element of the Bone Sialoprotein
showed that DlxHD-EnR inhibits endogenous levels of activity of the promotor in BHK21 cells, compared to control pCDNA3 or EnR alone (A) and that increased
doses of DlxHD-EnR counteract the transactivation of the promotor by Dlx5 (B). Second, the transfection of DlxHD-EnR prevents Runx2 activation by AcBMPR in
E6–6.5 calvaria cells in vitro and decreases the endogenous levels of expression of Runx2 in E6–6.5 mandibular mesenchyme in vitro (C).
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factors block Runx2 DNA binding activity and thus prevent the
precocious activation of the osteogenic program (Bialek et al.,
2004).The primary calvaria mesenchyme put in culture maintains
Twist, Prx1, and FgfR2 expression but does not express Dlx5 or
Runx2 above background (Fig. 5). Overexpression of Dlx5 does
not alter the proliferation rate of the cells or repress the
872 N. Holleville et al. / Developmental Biology 304 (2007) 860–874expression of these genes. The number of Prx1 or Twist-
positive cells is not significantly modified while FgfR2
expression is stimulated in the first few days in culture
(Fig. 5). The proliferation of the neural crest-derived frontal
calvaria was recently shown to depend upon a TGFβ-FGF
signaling pathway (Sasaki et al., 2006), whereas Dlx5 is
activated by BMPs but not by FGF signals (Holleville et al.,
2003). However, Dlx5 could participate indirectly in response
to proliferative signals, by enhancing FgfR2 expression of the
progenitors located at the OFs (Fig. 5M), in agreement with the
expression ofDlx5 in proliferating cells (Holleville et al., 2003).
The second domain defines committed osteoblast progeni-
tors. This area corresponds to Dlx5 and Runx2 expression
domains, and includes Goosecoid, Msx1, and FgfR2-positive
cells (Figs. 3 and 4). As soon as 24–48 h post-transfection, Dlx5
induces the osteogenic program, defined by Runx2 induction,
whereas the control cultures remain negative (Figs. 5 and 6).
This indicates that, at the time, they are harvested, the neural
crest-derived calvaria progenitors are not committed towards
osteoblast development, and that supplying Dlx5 to those cells
is sufficient to activate this program. Runx2 expression is
sustained for at least 4 days post-transfection (Fig. 6). This does
not exclude that a parallel pathway could cooperate to activate
Runx2 in vivo (e.g. Dlx6 or other genes). In addition, the fact
that the expression of Dlx5 itself is lost in the Runx2 mutant at
day 15.5 dpc (Choi et al., 2005), e.g. at a time when craniofacial
defects are already obvious in the Dlx5 mutant (Acampora
et al., 1999), indicates that the relationship between the two
genes may involve complex feedback loops for maintenance
of gene expression in vivo, especially during later stages of
bone development.
Moreover, additional Dlx5 presumptive target genes are
activated. Goosecoid, whose expression is decreased in Dlx5
mutant mice (Acampora et al., 1999), is activated by Dlx5 in the
cultures; Msx1, which is expressed around the developing
bones, is strongly activated in the cultures, whereas Msx2,
whose expression is comparable to background around the
membrane bones, is not increased by Dlx5 activation. This lack
of effect on Msx2 differs from the regulation of Msx2 reported
in the limb of Dlx5/Dlx6 mutants, wherein Msx2 expression is
lost in the mutant and restored upon Dlx5 re-activation
(Robledo et al., 2002). Taken together, these observations
suggest that, in this in vitro system, Dlx5 activates several genes
characteristic of committed osteoblasts, and that the calvaria
cells in culture retain some tissue-specific regulation. However,
some patterning information is lost, since Dlx5 overexpression
induced Dlx2 or Pitx2 in the calvaria cells, which do not
normally express these genes in vivo whereas mandibular
osteoblasts do. Future studies will explore which environmental
cues control these aspects of Dlx5 activity.
In the third domain, we define the differentiated osteoblasts
by their expression of FgfR1, osteopontin, and alkaline
phosphatase. Interestingly, overexpression of Dlx5 sequentially
activated these genes later than the genes defining committed
osteoblasts. FgfR1 expression appears at 48 h post-transfection,
osteopontin is weakly activated after 4 days, and alkaline
phosphatase is strongly activated after 16 days (Figs. 5 and 6).This result indicates that Dlx5 can initiate and drive a complete
bone differentiation program in immature, non committed
calvaria precursors.
Previous studies have suggested a difference between
embryonic bone development, involving Runx2 as a primary
osteogenic switch on one hand, and BMP2-induced bone
differentiation in cell lines where Dlx5 mediates BMP2 signals
to activate Runx2 on the other hand (reviewed in Ryoo et al.,
2006). Here, we reconcile the two models of bone differentia-
tion, showing that (i) Dlx5, which is induced by BMP2 in
prospective skull bone condensations as early as E8 in vivo
(Holleville et al., 2003), is also activated by BMPs in vitro, (ii)
Dlx5 can activate Runx2 and osteogenic differentiation in
uncommitted embryonic calvarial mesenchyme, and (iii) BMP
signals also activate Runx2 in the chick primary calvaria cells
grown in vitro and this induction depends on the activity of Dlx
factors.
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